MK-0893 Completed Phase 2 Trials for Type 2 Diabetes Mellitus Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT02004886A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
NCT00631488A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)